Abstract:Background: Gestational diabetes mellitus (GDM) is a known risk factor for macrosomia, with recent estimates suggesting that between 15-45% of newborns of mothers with GDM are macrosomic (vs. 12% in non-GDM mothers). This study’s objectives were to explore associations between both maternal GDM and children’s macrosomia and DNA methylation of eight genes selected based on a literature review of candidates potentially involved in GDM and obesogenic pathways ( IGF1 , IGF2 , H19 , ARHGRF11 , MEST , NR3C1 , Adiponectin , and RETN ). Methods: Data were taken from the Tianjin GDM Observational study, in the 4th-largest city in China; subjects were ages 24-49 and diagnosed with GDM between 2005-2009. Baseline surveys were completed from 2009-2011 for 580 enrolled women-child pairs; an additional 580 women-child pairs without GDM and frequency matched on child sex and birth date were enrolled. We examined 572 GDM cases vs. 573 non-GDM controls; of these 177 children were born with macrosomia (114 to women with GDM, p<0.001). Anthropometric measurements of all enrolled women were completed as part of usual prenatal care; blood draws for DNA methylation analysis (using the Illumina 850K array) were collected from children (median age 5.9 years, range 3.1-10.0). We used logistic regression for all analyses and adjusted for maternal height, age, smoking status, pre-pregnancy overweight/obesity, weight gain during pregnancy, parity, and hypertensive disorders of pregnancy as well as child sex and gestational age at delivery. FDR adjustment was used to correct all candidate gene CpG analyses for multiple testing, with FDR-adjusted P<0.05 considered statistically significant. Results: After analysis of 345 CpGs in eight target genes, one CpG was associated with macrosomia (cg14428359) and one with GDM (cg19466922) at FDR < 0.05; both CpGs were located in the gene MEST (3’ and 5’ untranslated regions, respectively). One additional CpG site in the promoter region of MEST (cg05862114) was associated with both GDM and macrosomia before FDR adjustment. All three CpGs were hypomethylated in both children of GDM mothers and macrosomia cases. Conclusions: MEST is a paternally imprinted gene that is highly expressed in fetal and placental tissue, and believed to play an important role in fetal development. It has also been found to have elevated expression in adipose tissue; epigenetic regulation of MEST may play an important role in the link between GDM and macrosomia.

Comprehensive Analysis of Gene Expression Profiles and DNA Methylome reveals Oas1, Ppie, Polr2g as Pathogenic Target Genes of Gestational Diabetes Mellitus

Comprehensive analysis of DNA methylation and gene expression profiles in gestational diabetes mellitus

Genome-wide DNA Methylation Profiling in Infants Born to Gestational Diabetes Mellitus

Increased Methylation at Differentially Methylated Region of GNASin Infants Born to Gestational Diabetes

Epigenetic Alternations of Micrornas and DNA Methylation Contribute to Gestational Diabetes Mellitus.

DNA Methylation Profiles in Placenta and Its Association with Gestational Diabetes Mellitus.

Identification of hub-methylated differentially expressed genes in patients with gestational diabetes mellitus by multi-omic WGCNA basing epigenome-wide and transcriptome-wide profiling

Placental Delta-Like 1 Gene DNA Methylation Levels Are Related to Mothers’ Blood Glucose Concentration

Placental DNA methylation changes in the development of gestational diabetes mellitus

Deciphering DNA Methylation in Gestational Diabetes Mellitus: Epigenetic Regulation and Potential Clinical Applications

Identification of biological processes and genes for gestational diabetes mellitus

Identification of potential gene markers in gestational diabetes mellitus

Placental DNA methylation changes in gestational diabetes mellitus

Study on the relationship between DNA methylation of target CpG sites in peripheral blood and gestational diabetes during early pregnancy

Analysis, validation, and discussion of key genes in placenta of patients with gestational diabetes mellitus

Epigenetic Regulation and Potential Clinical Applications

Predicting of Disease Genes for Gestational Diabetes Mellitus Based on Network and Functional Consistency.

Related Genes in Pathogenesis of Gestational Diabetes Mellitus

Genome-Wide Placental Gene Methylations in Gestational Diabetes Mellitus, Fetal Growth and Metabolic Health Biomarkers in Cord Blood

Epigenetic marks associated with gestational diabetes mellitus across two time points during pregnancy

Abstract P073: A Novel Epigenetic Link Between Gestational Diabetes Mellitus and Macrosomia